Diazepam (Valium) in Pregnancy: Not Recommended
Diazepam should be avoided during pregnancy whenever possible, particularly in late pregnancy, due to significant risks of neonatal sedation, withdrawal syndrome, and potential miscarriage. 1, 2
Key Safety Concerns
Neonatal Effects from Late Pregnancy Use
The FDA drug label explicitly warns that use of Valium late in pregnancy can result in serious neonatal complications 1:
- Sedation syndrome: respiratory depression, lethargy, hypotonia
- Withdrawal syndrome: hyperreflexia, irritability, restlessness, tremors, inconsolable crying, feeding difficulties
- Labor/delivery complications: fetal heart rate irregularities, poor sucking, hypothermia, moderate respiratory depression
These effects are particularly concerning because neonatal enzyme systems for drug metabolism are not fully developed, especially in premature infants 1.
Miscarriage Risk
A 2024 nationwide case-time-control study found benzodiazepine use during pregnancy was associated with a 69% increased risk of miscarriage (OR 1.69,95% CI 1.52-1.87) 2. This finding remained consistent across multiple sensitivity analyses and was unlikely due to unmeasured confounding.
Teratogenicity Data
The evidence on major congenital malformations is reassuring but not definitive 1, 3:
- Published observational studies do not report a clear association with major birth defects 1
- A 2003 Hungarian case-control study of short-term diazepam use found no detectable teratogenic risk 3
- Animal studies showed teratogenicity (cleft palate, encephalopathy) only at high, maternally toxic doses (≥8 times human doses) 1
However, early studies from the 1970s suggested possible associations with facial clefts and cardiac malformations, though later studies have not consistently confirmed these findings 4.
Clinical Decision-Making Algorithm
If Benzodiazepine is Absolutely Necessary:
Avoid first trimester use when risk of congenital malformations is greatest 1, 5
Use the lowest effective dose for the shortest duration 1, 5
Consider alternatives with longer safety records:
- Chlordiazepoxide appears safer during pregnancy and lactation 5
- Non-pharmacologic interventions should be maximized
Monitor neonates closely for signs of:
- Sedation and respiratory depression
- Withdrawal symptoms (can last weeks to months) 1
- Feeding problems and hypotonia
Special Considerations
Concurrent benzodiazepine and opioid use is particularly dangerous - methadone may be more appropriate than buprenorphine if concurrent benzodiazepine use is unavoidable in opioid use disorder treatment 6.
Breastfeeding
Breastfeeding is NOT recommended during Valium treatment 1. Diazepam is excreted in breast milk and can cause lethargy, sedation, and weight loss in infants 5.
Pregnancy Registry
Healthcare providers should register patients by calling the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 1.
Common Pitfalls to Avoid
- Do not assume "short-term use is safe" - even brief exposure carries miscarriage risk 2
- Do not continue routine use into late pregnancy - neonatal effects are most severe with third trimester exposure 4
- Do not underestimate withdrawal duration - neonatal symptoms can persist for months 1
- Do not combine with opioids - dramatically increases respiratory depression risk 1